What Is Laser Therapy?

Laser therapy, clinically termed low-level laser therapy (LLLT) or photobiomodulation therapy (PBMT), involves the application of specific wavelengths of light—typically in the red to near-infrared spectrum (600–1,100 nm)—to injured or inflamed tissues. Unlike surgical lasers that cut or ablate, therapeutic lasers operate at low power densities (typically 5–500 mW) and deliver energy that is absorbed by cellular chromophores, primarily cytochrome c oxidase in the mitochondria. This non-invasive modality has gained traction in sports medicine, orthopedics, and rehabilitation as a complementary intervention for chronic injuries that fail to respond to conventional treatments. Its appeal lies in its safety profile, ease of use, and ability to target deep structures without tissue damage. Chronic injuries, defined as those persisting beyond the expected healing time of three to six months, often involve a cycle of low-grade inflammation, reduced tissue perfusion, and altered cellular metabolism—each a target for photobiomodulation.

Mechanisms of Action

The therapeutic effects of laser therapy are rooted in photobiomodulation—a well-characterized process where photon energy triggers intracellular signaling cascades. At the cellular level, this translates to enhanced metabolism, reduced oxidative stress, and modulated inflammatory responses. Understanding these mechanisms is critical for clinicians to select appropriate treatment parameters and anticipate patient responses.

Cellular Energy Production

Absorbed light stimulates the mitochondrial respiratory chain, increasing adenosine triphosphate (ATP) synthesis. This energy surplus fuels protein synthesis, cell proliferation, and migration—all essential for tissue repair. Chronically injured tissues often exhibit low ATP levels and mitochondrial dysfunction; laser therapy helps restore normal metabolic activity. Studies using in vitro models have shown that LLLT can increase ATP production by up to 150 % in fibroblasts and tenocytes, the primary cells responsible for tendon and soft tissue healing. In vivo, this translates to faster collagen deposition and improved tensile strength in healing tendons. The effect is dose-dependent: too little energy fails to stimulate, while excessive energy can inhibit mitochondrial function (biphasic dose response).

Anti-inflammatory Effects

Laser irradiation modulates the expression of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukins (IL-1β, IL-6). It upregulates anti-inflammatory mediators like interleukin‑10 and stimulates the release of nitric oxide, which improves microvascular perfusion. This dual action reduces edema and chronic inflammation—key drivers of persistent pain and dysfunction in conditions like tendinitis and bursitis. Chronic low-grade inflammation is often the barrier to full recovery; laser therapy helps shift the tissue environment toward a regenerative state. Additionally, laser therapy promotes the resolution of inflammation by enhancing lymphatic drainage and reducing neutrophil infiltration, which is particularly beneficial in conditions such as chronic plantar fasciitis and recalcitrant tennis elbow.

Pain Modulation

Analgesic effects occur through multiple pathways: increased beta-endorphin release, reduced nerve conduction velocity in small C-fibers, and blockade of sodium channels in nociceptors. Clinically, patients often report immediate pain relief after treatment, even before significant tissue healing occurs. This makes laser therapy particularly valuable for chronic pain syndromes where central sensitization has taken hold. Additionally, by decreasing inflammatory mediators, laser therapy indirectly reduces the chemical stimulation of pain receptors. The analgesic effect is typically transient (lasting hours to days) but becomes cumulative with repeated sessions, allowing patients to engage more fully in exercise-based rehabilitation without symptom exacerbation.

Improved Microcirculation and Angiogenesis

Photobiomodulation stimulates the release of vascular endothelial growth factor (VEGF) and upregulates endothelial nitric oxide synthase, promoting angiogenesis and improving local blood flow. In chronic injuries, poor vascularity—such as the hypovascular zones of the Achilles tendon or the rotator cuff—impedes healing. Laser therapy helps restore perfusion, delivering oxygen and nutrients while removing metabolic waste products. This effect is often observed as visible erythema in the treated area during and immediately after therapy.

Clinical Applications for Chronic Injuries

While acute trauma may respond to laser therapy as well, its role in chronic injury management is especially pronounced because these conditions involve prolonged healing phases, scarring, and persistent inflammation. Practitioners commonly apply it to the following categories, with the strongest evidence supporting tendinopathies and osteoarthritis.

Tendinopathies

Chronic tendinopathy—such as Achilles tendinopathy, lateral epicondylitis (tennis elbow), and patellar tendinopathy—often involves degenerative changes rather than frank inflammation. Laser therapy promotes collagen synthesis and alignment, improves vascularity in hypo-vascular zones, and reduces pain. A 2023 systematic review in the Journal of Orthopaedic & Sports Physical Therapy found moderate-to-strong evidence for LLLT reducing pain and improving function in chronic lateral epicondylitis when used with exercise. For Achilles tendinopathy, a 2022 meta-analysis of seven RCTs reported significant reductions in the Victorian Institute of Sports Assessment-Achilles (VISA-A) scores with laser therapy plus eccentric loading compared to sham plus exercise. Optimal parameters for tendinopathy typically require higher fluences (8–15 J/cm²) and near-infrared wavelengths (810–980 nm) to reach the tendon depth.

Specific Protocols for Common Tendinopathies

For lateral epicondylitis, the World Association for Laser Therapy (WALT) recommends 4–8 J/cm² at 810 nm applied to the common extensor origin, with 8–12 sessions over 4–6 weeks. For patellar tendinopathy, 6–10 J/cm² at 904 nm (pulsed) to the inferior pole of the patella, combined with quadriceps strengthening, yields superior outcomes. Clinicians should note that tendinopathy often requires longer treatment courses than acute strains due to the chronic degenerative nature of the condition.

Osteoarthritis

Mild-to-moderate knee osteoarthritis (KOA) is one of the most studied conditions for laser therapy. A 2021 Cochrane review that included 22 RCTs concluded that LLLT reduces pain and improves function in KOA with effect sizes comparable to those of NSAIDs, but without gastrointestinal or renal side effects. The best results occur when laser is applied to the medial and lateral joint lines using an 810–830 nm wavelength at 4–6 J/cm² per point, 2–3 times per week for 4–8 weeks. Patients with synovitis and effusion tend to respond more favorably than those with advanced bone-on-bone changes. Laser therapy for hand and hip osteoarthritis is less studied but shows promise, particularly for pain reduction in carpometacarpal osteoarthritis.

Bursitis

Chronic bursitis, particularly of the shoulder (subacromial) and hip (trochanteric), can be refractory to corticosteroid injections and physical therapy. Laser therapy’s anti-inflammatory and pro-angiogenic effects help resolve fluid accumulation and reduce capsular irritation. Repeated treatments over several weeks often lead to sustained symptom relief without the side effects of steroids. For subacromial bursitis, a typical protocol involves scanning the bursal area with a 904 nm pulsed laser at 5–10 J/cm², 3 times per week for 3–4 weeks. Combining laser with manual therapy and corrective exercises addresses the underlying biomechanical contributors, such as scapular dyskinesis.

Muscle Strains and Myofascial Pain

Overuse muscle injuries and myofascial trigger points respond well to laser therapy. It accelerates muscle fiber regeneration, reduces fibrosis, and alleviates referred pain patterns. In chronic low back pain with a muscular component, laser therapy combined with stretching has shown superior outcomes compared to sham or exercise alone in randomized trials. The analgesic effect on trigger points can be immediate and is thought to result from the inhibition of acetylcholine release at the motor endplate, reducing contracture. For chronic neck pain associated with trapezius trigger points, 660 nm red laser at 4–6 J/cm² applied directly to the points for 10–15 seconds each is effective when repeated over 2–3 weeks.

Other Chronic Conditions

Evidence also supports laser therapy for plantar fasciitis, knee osteoarthritis (especially mild-to-moderate cases), carpal tunnel syndrome, and post-surgical scars that remain painful and stiff. Emerging research explores its utility in chronic wound healing and neuropathic pain, though these applications require more controlled studies. For plantar fasciitis, a 2020 systematic review found that LLLT combined with calf stretching and orthotics reduced heel pain more effectively than stretching alone, with benefits persisting at 6-month follow-up. In carpal tunnel syndrome, low-level laser applied over the carpal tunnel (810 nm, 8 J/cm²) three times weekly for five weeks improved nerve conduction velocity and symptom severity scores in two independent RCTs.

Evidence Base

Over 4,000 peer-reviewed studies have been published on photobiomodulation, and more than 100 human randomized controlled trials specifically address chronic musculoskeletal conditions. Meta-analyses by the World Association for Laser Therapy (WALT) and independent researchers consistently report significant reductions in pain (effect sizes of 0.4–0.8) and improvements in function for conditions like chronic neck pain, shoulder impingement, and knee osteoarthritis. However, evidence is strongest for wavelengths around 660 nm (red) and 810–830 nm (near-infrared), with higher fluences (energy density) required for deep structures. A 2021 Cochrane review noted that while overall quality is moderate, consistent findings across multiple endpoints support clinical effectiveness when proper parameters are used. Negative trials often use inadequate doses, incorrect wavelengths, or insufficient treatment frequency—highlighting the importance of parameter selection.

Critically, the literature emphasizes that laser therapy is not a substitute for active rehabilitation but a powerful adjunct. Combining LLLT with therapeutic exercise produces synergistic outcomes—the laser reduces pain and inflammation, allowing patients to progress through strengthening and motor control exercises with less discomfort. This is especially important in chronic conditions where fear of pain and movement avoidance perpetuate disability. Clinicians are encouraged to consult WALT treatment recommendations for evidence-based dosage guidelines. Additionally, the PROSPERO registry lists ongoing systematic reviews that will further clarify optimized protocols for specific conditions.

Treatment Protocols and Parameters

The effectiveness of laser therapy is highly parameter-dependent. Key variables include:

  • Wavelength: Deeper tissues require longer wavelengths (810–980 nm) for optimal penetration; superficial conditions respond to red (635–660 nm). Near-infrared penetrates up to 3–5 cm, while red only reaches 1–2 cm. For tendinopathies and joint capsules, 904 nm (gallium arsenide) is preferred due to its high peak power and deep tissue penetration.
  • Power and Energy Density: Typical doses range from 4–10 J/cm² for superficial injuries to 10–20 J/cm² for deep structures. Higher power (up to 5 W) allows shorter treatment times but must be delivered with caution to avoid thermal effects. Clinicians should calculate total energy based on the size of the treatment area: a 10 cm² area treated at 6 J/cm² requires 60 J total delivered energy.
  • Pulse or Continuous Mode: Pulsed delivery (e.g., 10–100 Hz) may reduce photobleaching and allow higher peak power while minimizing tissue heating, though continuous mode is still standard for most applications. Pulsed modes are often preferred for deeper structures and for patients who report sensitivity to the laser sensation.
  • Frequency and Duration: Chronic cases typically require 8–12 sessions over 3–6 weeks, often tapering to maintenance treatments. Detrimental effects have been observed with excessive dosing (e.g., daily high fluences), so clinicians must adhere to established protocols. An initial phase of 2–3 treatments per week for 3–4 weeks is standard, followed by weekly sessions for another 4 weeks if needed. Maintenance sessions can be biweekly or monthly.

The National Center for Biotechnology Information hosts a comprehensive review of recommended parameters for various conditions, which serves as a clinical reference. Individual patient factors—skin pigmentation, tissue depth, and chronicity—also influence response. Darker skin absorbs more energy at shorter wavelengths, so clinicians may need to increase fluence or shift to near-infrared to achieve equivalent tissue dose. Devices registered by the FDA as Class II medical devices require prescription or professional application, though consumer-grade units exist for home use at lower power levels. Class IV laser devices (>500 mW) are increasingly used in clinical settings for their ability to deliver therapeutic doses quickly.

Practical Tips for Clinicians

Before treatment, always clean the skin of lotions, oils, or dressings that may affect light transmission. Place the probe perpendicular to the skin with light contact; scanning the area slowly (1–2 cm/s) ensures even energy distribution. For small joints (e.g., wrist or ankle), use a smaller spot size or grid pattern to cover the entire joint capsule. Reassess pain and function after the third session; if no response, consider adjusting parameters (increase energy density by 20–30%, change wavelength, or add pulsed mode). Document total energy delivered per session per anatomical area for outcome tracking and billing purposes.

Benefits and Advantages

Laser therapy offers several distinct advantages over more invasive or pharmacologic treatments:

  • Non-invasive and painless (patients feel only mild warmth)
  • No known systemic side effects or drug interactions
  • Reduces reliance on NSAIDs, opioids, and corticosteroid injections
  • Short treatment sessions (5–15 minutes per area) with no downtime
  • Can be applied over surgical hardware or implants without interference
  • Cost-effective compared to repeated procedures or long-term medication
  • Integrates seamlessly with manual therapy, exercise, and other modalities
  • Applicable to patients who cannot tolerate medications, such as those with chronic kidney disease or gastrointestinal bleeding risks from NSAIDs
  • No risk of tendon or cartilage damage, unlike repeated corticosteroid injections

These attributes make laser therapy particularly attractive for athletes, active adults, and patients who wish to avoid surgery or who require a non-pharmacologic pain management strategy. Nonetheless, realistic expectations must be set: results are cumulative, and a single session is unlikely to provide lasting relief for chronic conditions. A course of therapy is typically required, and some patients may need periodic maintenance treatments every 4–6 weeks to sustain benefits.

Limitations and Considerations

Despite its promise, laser therapy is not a panacea. Key limitations include:

  • Variable response: Genetics, tissue depth, and the presence of scar tissue or fibrosis can alter outcomes. Some patients do not respond regardless of correct dosage. Non-responders may have polymorphisms in cytochrome c oxidase genes or excessive melanin absorption. In such cases, alternative or adjunctive modalities should be considered.
  • Lack of standardization: The proliferation of devices with different outputs and marketing claims makes it difficult for clinicians to choose reliably. Best practices are still evolving, and reimbursement by insurance remains inconsistent in many jurisdictions. Many commercial “cold laser” devices for home use produce too low power (1–5 mW) to achieve therapeutic effects at depth. Clinicians should seek devices that provide objective power measurement and are listed with the FDA or equivalent regulatory body.
  • Contraindications: Laser therapy is contraindicated over the thyroid gland, directly over the eyes (risk of retinal damage), over malignancies unless part of an oncologic protocol, and over pregnant abdomens. Proper eye protection (specific to the laser wavelength) is mandatory for both patient and practitioner. Relative contraindications include active infection, photosensitivity disorders, and pacemaker sites (though modern devices are generally safe if not directly over the device).
  • Not a standalone cure: Chronic injuries often have underlying biomechanical, postural, or load-management issues that must be addressed concurrently. Laser therapy accelerates healing but does not correct movement patterns or structural imbalances. Behavioral factors such as sleep quality, nutrition, and stress management also influence chronic pain outcomes and should be integrated into the treatment plan.

Patients and educators should be aware that many commercially available “cold laser” devices for home use produce insufficient power for deep injuries. Professional-grade units (Class IV) deliver higher output but require training to avoid over-dosing. Consultation with a licensed healthcare professional—preferably one certified by an organization such as the American Laser Therapy Network—is strongly advised before initiating treatment. Additionally, clinicians should verify that their liability insurance covers laser therapy, as some policies require specific certifications.

Future Directions

Research continues to refine optimal parameters and explore combination therapies. Promising areas include:

  • Combining laser therapy with platelet-rich plasma (PRP) or stem cell injections to potentiate biologic effects. Early evidence suggests that LLLT applied immediately after PRP injection can enhance growth factor release and cell proliferation.
  • Developing wearable devices that deliver transcutaneous photobiomodulation for chronic pain management over longer periods, allowing patients to self-administer treatment between clinic visits.
  • Using near-infrared spectroscopy to personalize dosimetry based on real-time tissue oxygenation, enabling adaptive dose adjustments during treatment.
  • Investigating the role of laser therapy in neuropathic pain and central sensitization, where conventional pain treatments are often inadequate. Preclinical studies show that PBMT reduces neuroinflammation and modulates glial cell activity.
  • Exploring transcranial photobiomodulation for chronic pain and associated mood disorders, though this is an emerging frontier requiring more safety and efficacy data.
  • Standardizing reporting of laser parameters in clinical trials per the WALT guidelines to improve reproducibility and meta-analysis quality.

As the evidence base expands, laser therapy may become a first-line option for many chronic musculoskeletal conditions rather than a last resort. Educational curricula in physiotherapy, athletic training, and sports medicine are beginning to incorporate photobiomodulation science, equipping future clinicians with the knowledge to apply it effectively. Professional organizations such as the North American Association for Photobiomodulation Therapy (NAALT) offer certification programs to standardize practitioner training.

Conclusion

Laser therapy represents a valuable, evidence-supported tool in the management of chronic injuries. By harnessing photobiomodulation to reduce inflammation, accelerate tissue repair, and modulate pain, it offers a non-invasive option that complements traditional rehabilitation. While not universally effective and highly parameter-dependent, its safety profile and growing clinical support make it a promising modality for conditions that often prove stubborn to other treatments. Health professionals and students should stay current with primary research—such as that published in journals indexed by PubMed—to apply laser therapy appropriately and avoid the pitfalls of under-dosing or over-marketing. With continued integration into practice and education, laser therapy has the potential to improve outcomes and reduce the burden of chronic injury on individuals and healthcare systems alike. Clinicians who master the principles of photobiomodulation will be better equipped to offer their patients a safe, effective, and drug-free path toward recovery from persistent pain and dysfunction.